Kombinasi Ekstrak Etanol 96% Daun Teh (Camellia sinensis (L.) Kuntze) dan Daun Yakon (Smallanthus sonchifolius) sebagai Penghambat Enzim ?-glukosidase

Combination of 96% Ethanol Extract of Tea Leaves (Camellia sinensis Linn.) and Yakon Leaves (Smallanthus sonchifolius) as an Inhibitor of the ?-glucosidase enzyme

Authors

  • Lilik Sulastri Sekolah Tinggi Teknologi Industri dan Farmasi (STITIF) Jl. Kumbang 23 Bogor 16151
  • Rohmat Hidayat Sekolah Tinggi Teknologi Industri dan Farmasi (STITIF) Jl. Kumbang 23 Bogor 16151
  • Padmono Citroreksoko Sekolah Tinggi Teknologi Industri dan Farmasi (STITIF) Jl. Kumbang 23 Bogor 16151
  • Syamsudin Abdillah Program Doktor Fakultas Farmasi, Universitas Pancasila, Srengseng Sawah, Jagakarsa, Jakarta Selatan
  • Partomuan Simanjuntak Pusat Riset Kimia, Badan Riset dan Inovasi Nasional (BRIN), Kawasan Puspiptek, Serpong, Tangerang Selatan

DOI:

https://doi.org/10.25026/mpc.v14i1.563

Keywords:

α-glukosidase enzyme inhibitor, Camellia sinensis, Smallanthus sonchifolius, diabetes mellitus

Abstract

Diabetes mellitus is a degenerative disease in the form of metabolic disorders characterized by increased blood glucose levels and impaired insulin metabolism. Yakon leaves and tea leaves contain phenolic compounds which have ?-glucosidase inhibiting activity. The aims of this study was to determine the inhibitory activity of the ?-glucosidase enzyme from tea leaf and yakon leaf extracts and the combination of the two plants. Extraction of the active compounds contained in tea leaves and yakon leaves was carried out by graded maceration method using n-hexane, ethyl acetate, 96% ethanol and water as solvents (using the decoction method). Phytochemical analysis of 96% ethanol extract of tea leaves and yakon leaves contained alkaloids, flavonoids, tannins, saponins, triterpenoids/steroids and phenols. The results of testing the inhibitory activity of the -glucosidase enzyme showed that the IC50 values ??for 96% ethanol extract of tea leaves and yakon leaves were 22.31 and 19.70 ppm, respectively. Combination of 96% ethanol extract of tea leaves and yakon leaves in a ratio of 1:1; 1:3; 3:1 obtained IC50 of 64.73 ppm respectively; 7.34 ppm, and 11.03 ppm.

References

Y. Seino et al., “Report of the committee on the classification and diagnostic criteria of diabetes mellitus,” J. Diabetes Investig., vol. 1, no. 5, pp. 212–228, 2010, doi: 10.1111/j.2040-1124.2010.00074.x.

Y. Liu, J. Sun, S. Rao, Y. Su, and Y. Yang, “Antihyperglycemic, antihyperlipidemic and antioxidant activities of polysaccharides from Catathelasma ventricosum in streptozotocin-induced diabetic mice,” Food Chem. Toxicol., vol. 57, pp. 39–45, 2013, doi: 10.1016/j.fct.2013.03.001.

A. Einstein, “Unraveling the causes of Diabetes,” vol. 296, pp. 686–689, 2002.

P. Zimmet, K. G. M. M. Alberti, and J. Shaw, “Global and societal implications of the diabetes epidemic,” Nature, vol. 414, no. 6865, pp. 782–787, 2001, doi: 10.1038/414782a.

roglic gojka wild sarah, “Estimates for the year 2000 and projections for 2030,” World Health, vol. 27, no. 5, 2004.

G. Roglic et al., “The burden of mortality attributable to diabetes: Realistic estimates for the year 2000,” Diabetes Care, vol. 28, no. 9, pp. 2130–2135, 2005, doi: 10.2337/diacare.28.9.2130.

R. E. McCaa, C. S. McCaa, D. G. Read, J. D. Bower, and A. C. Guyton, International Diabetes Federation Diabets Atlas, 7th ed., vol. 31, no. 4. Karakas, 2015.

J. J. Marín-Peñalver, I. Martín-Timón, C. Sevillano-Collantes, and F. J. del Cañizo-Gómez, “Update on the treatment of type 2 diabetes mellitus,” World J. Diabetes, vol. 7, no. 17, p. 354, 2016, doi: 10.4239/wjd.v7.i17.354.

C. F. Deacon, “A review of dipeptidyl peptidase-4 inhibitors. Hot topics from randomized controlled trials,” Diabetes, Obes. Metab., vol. 20, no. October 2017, pp. 34–46, 2018, doi: 10.1111/dom.13135.

M. M. Kantorovich, “Camellia Sinensis?: A review,” Voen. zhurnal, vol. 8, no. 2, pp. 78–79, 2012.

L. Zhang, C. T. Ho, J. Zhou, J. S. Santos, L. Armstrong, and D. Granato, “Chemistry and Biological Activities of Processed Camellia sinensis Teas: A Comprehensive Review,” Compr. Rev. Food Sci. Food Saf., vol. 18, no. 5, pp. 1474–1495, 2019, doi: 10.1111/1541-4337.12479.

“Mercado?.pdf.” .

G. Zhou, Y. Zhao, J. Han, C. Feng, and H. Huang, “Research on submicron particle sampler based on inertial impactor,” Yi Qi Yi Biao Xue Bao/Chinese J. Sci. Instrum., vol. 31, no. 6, pp. 1381–1386, 2010.

Y. Köksal and S. Penez, “Evaluation Of Thyroid Dysfunction In Type 2diabetic Patients In Sokoto Metropolis,” Metrologia, vol. 53, no. 5, pp. 1–116, 2015, doi: 10.1590/s1809-98232013000400007.

R. Djamil, W. Winarti, and P. Simanjuntak, “Standardization and ? -glycosidase inhibition of extracts of Vatica pauciflora Blume stem barks and Smallanthus sonchifolius leaves,” vol. 3, no. 4, pp. 42–46, 2014.

J. Lachman, E. C. Fernández, and M. Orsák, “Yacon [Smallanthus sonchifolia (Poepp. et Endl.) H. Robinson] chemical composition and use - A review,” Plant, Soil Environ., vol. 49, no. 6, pp. 283–290, 2003, doi: 10.17221/4126-pse.

J. B. Harborne, Phytochemical methods, Third Edit. London New York, 2006.

Z. Aziz, F. H. Al Qisthi, N. D. Yuliana, and P. Simanjuntak, “Identification of ?-glucosidase Enzyme Inhibitor Compound from Ethanol 96% Extract of Yakon Leaves (Smallanthus sonchifolius [Poepp.& Endl.] H. Robinson),” J. Ilmu Kefarmasian Indones., vol. 17, no. 1, p. 21, 2019, doi: 10.35814/jifi.v17i1.652.

K. Indarti, E. F. Apriani, A. E. Wibowo, and P. Simanjuntak, “Antioxidant Activity of Ethanolic Extract and Various Fractions from Green Tea (Camellia sinensis L.) Leaves,” Pharmacogn. J., vol. 11, no. 4, pp. 771–776, 2019, doi: 10.5530/pj.2019.11.122.

Downloads

Published

2021-12-31

How to Cite

Sulastri, L., Hidayat, R., Citroreksoko, P., Abdillah, S., & Simanjuntak, P. (2021). Kombinasi Ekstrak Etanol 96% Daun Teh (Camellia sinensis (L.) Kuntze) dan Daun Yakon (Smallanthus sonchifolius) sebagai Penghambat Enzim ?-glukosidase: Combination of 96% Ethanol Extract of Tea Leaves (Camellia sinensis Linn.) and Yakon Leaves (Smallanthus sonchifolius) as an Inhibitor of the ?-glucosidase enzyme. Proceeding of Mulawarman Pharmaceuticals Conferences, 14(1), 145–152. https://doi.org/10.25026/mpc.v14i1.563